Rosuvastatin in patients with elevated C-reactive protein

N Engl J Med. 2009 Mar 5;360(10):1041; author reply 1041-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biomarkers / blood
  • C-Reactive Protein / metabolism
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Cause of Death
  • Fluorobenzenes / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Kaplan-Meier Estimate
  • Pyrimidines / therapeutic use*
  • Risk
  • Rosuvastatin Calcium
  • Sulfonamides / therapeutic use*

Substances

  • Biomarkers
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium
  • C-Reactive Protein